News
High intake of the artificial sweetener sucralose may reduce the efficacy of ICIs in patients with cancer, data suggest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback